A CLINICAL PHARMACOLOGICAL APPROACH TO THE RATIONAL USE OF DRUGS IN DEPRESSIVE SYNDROME

Authors

  • Urinboyev Lochinbek Khasanboy ugli Assistant Trainee of the Department "Pharmacology, Clinical Pharmacology and Medical Biotechnologies", ASMI

Keywords:

depression, biochemical changes, antidepressant effect, emotions, monoamines, anticholinergic drugs.

Abstract

A review of the literature on the neurobiological mechanisms of depressive disorders, which presents the role of biochemical changes in the cholinergic, serotonergic, dopaminergic and other neurohumoral systems in the development of depression. Modern approaches to the pharmacocorrection of depressive disorders are discussed in detail, and the question of the prospects of treating depression with anticholinergic drugs is also raised.

References

Aleksandrovsky Yu. A. Borderline mental disorders. - M.: 2010. - 496 p.

Ashmarin I.P., Stukalov P.V., Eshchenko N.D. Biochemistry of the brain: Uch. allowance. - St. Petersburg, 2019. - 328 p.

Borodin V.I., Kanaeva L.S., Mironova N.V., Zakharova K.V. Clinical efficacy and tolerability of the drug “Cipralex” (escitalopram) in the treatment of mild and moderately severe depression // Psychiatry and psychopharmacotherapy. — 2015 — T. 7, No. 5. — P. 3–6.

Vein A.M., Voznesenskaya T.G., Golubev V.L., Dyukova G.M. Depression in neurological practice. - M., 2012. - P. 30–44.

Vertogradova O. P. Depression (psychopathology, pathogenesis). - M., 2010.

Downloads

Published

2024-04-12

Issue

Section

Articles